✦ LIBER ✦

Selegiline as primary treatment in early phase Parkinson's disease — an interim report

✍ Scribed by V. V. Myllylä; K. A. Sotaniemi; J. Tuominen; E. H. Heinonen

Book ID: 114782840
Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 332 KB
Volume: 80
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1989.tb01799.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selegiline as a primary treatment of Par

Selegiline as a primary treatment of Parkinson's disease

✍ V. V. Myllylä; K. A. Sotaniemi; J. A. Vuorinen; E. H. Heinonen 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

Lisuride plus selegiline in the treatmen

Lisuride plus selegiline in the treatment of early Parkinson's disease

✍ G. Nappi; E. Martignoni; R. Horowski; C. Pacchetti; E. Rainer; P. Bruggi; I. Run 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

Selegiline as the primary treatment of P

Selegiline as the primary treatment of Parkinson's disease — a long-term double-blind study

✍ V. V. Myllylä; K. A. Sotaniemi; P. Hakulinen; O. Mäki-lkola; E. H. Heinonen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Double-blind, crossover placebo controll

Double-blind, crossover placebo controlled trial of selegiline in Parkinson's disease — an interim analysis

✍ P. F. Teychenne; S. Parker 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

Selegiline ? An overview of its role in

Selegiline ? An overview of its role in the treatment of Parkinson's disease

✍ Wessel, K. ;Szelenyi, I. 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 389 KB

Selegiline (10 mg per day) selectively inhibits monoamine oxidase type B and thus thwarts the metabolism of dopamine by this enzyme. Selegiline has been used in the therapy of Parkinson's disease since 1986. It enhances the efficacy of levodopa, allows a reduction of the levodopa dose, and improves

Treatment of Parkinson's disease in earl

Treatment of Parkinson's disease in early and late phases. Use of pharmacological agents with special reference to deprenyl (selegiline)

✍ MELVIN D. YAHR; MARINA R. MENDOZA; DANIEL MOROS; KENNETH J. BERGMANN 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB